Vigilant Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-60
Closed -$10K 438
2019
Q2
$10K Buy
60
+19
+46% +$2.63K ﹤0.01% 348
2019
Q1
$6K Sell
41
-540
-93% -$78.3K ﹤0.01% 377
2018
Q4
$78K Buy
581
+81
+16% +$13.3K 0.01% 205
2018
Q3
$95K Sell
500
-1,473
-75% -$271K 0.01% 209
2018
Q2
$329K Buy
1,973
+217
+12% +$34.8K 0.05% 91
2018
Q1
$296K Buy
1,756
+1,471
+516% +$247K 0.04% 108
2017
Q4
$47K Sell
285
-529
-65% -$94.9K 0.01% 228
2017
Q3
$167K Hold
814
0.02% 115
2017
Q2
$198K Hold
814
0.03% 108
2017
Q1
$194K Hold
814
0.03% 107
2016
Q4
$171K Hold
814
0.03% 115
2016
Q3
$187K Sell
814
-686
-46% -$168K 0.03% 116
2016
Q2
$347K Hold
1,500
0.07% 87
2016
Q1
$402K Hold
1,500
0.08% 76
2015
Q4
$469K Buy
+1,500
New +$447K 0.1% 78
2015
Q2
Sell
-1,500
Closed -$446K 294
2015
Q1
$446K Hold
1,500
0.08% 85
2014
Q4
$386K Buy
1,500
+1,488
+12,400% +$372K 0.08% 90
2014
Q3
$3K Buy
+12
New +$2.69K ﹤0.01% 276

Other funds holding AGN

Vigilant Capital Management's AGN Position: Q3 2019 in Review

Vigilant Capital Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 60 shares — an estimated $10K sold.

Vigilant Capital Management first reported a position in AGN in Q3 2014 and held it in 18 quarters. The position peaked at $469K in Q4 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Vigilant Capital Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Vigilant Capital Management sold 60 Allergan plc shares in Q3 2019, an estimated $10K.
  • Vigilant Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 18 quarters.
  • Vigilant Capital Management's Allergan plc position peaked at $469K in Q4 2015.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Vigilant Capital Management's 13F filing for Q3 2019, filed 16 Oct 2019.